ArticleFrontiers in cell and developmental biology2022

MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated.

Silvia López-Borrego et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.